Free Trial

Lilia-Celine Lozada Analyst Performance

Analyst at JPMorgan Chase & Co.

Lilia-Celine Lozada is a stock analyst at JPMorgan Chase & Co. in the medical sector, covering 4 publicly traded companies. Over the past year, Lilia-Celine Lozada has issued 6 stock ratings, including buy, hold, and sell recommendations. While full access to Lilia-Celine Lozada's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Lilia-Celine Lozada's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
8 Last 1 Years
Buy Recommendations
37.50% 3 Buy Ratings
Companies Covered
4 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy37.5%3 ratings
Hold50.0%4 ratings
Sell12.5%1 ratings

Out of 8 total stock ratings issued by Lilia-Celine Lozada at JPMorgan Chase & Co., the majority (50.0%) have been Hold recommendations, followed by 37.5% Buy and 12.5% Sell.

Exchange Coverage

ExchangePercentageCount
NASDAQ
75.0% of companies on NASDAQ
3 companies
NYSE
25.0% of companies on NYSE
1 company

Lilia-Celine Lozada, an analyst at JPMorgan Chase & Co., currently covers 4 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
4 companies
100.0%

Lilia-Celine Lozada of JPMorgan Chase & Co. specializes in stock coverage within the Medical sector.

Coverage Industries

IndustryPercentage
MED PRODUCTS
2 companies
50.0%
MED INSTRUMENTS
1 company
25.0%
MED/DENTAL - SUPP
1 company
25.0%

Lilia-Celine Lozada's Ratings History at JPMorgan Chase & Co.

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
AtriCure, Inc. stock logo
ATRC
AtriCure
2/11/2026Downgrade$37.82$36.00Neutral
Envista Holdings Corporation stock logo
NVST
Envista
2/6/2026Boost Price Target$29.03$26.00Neutral
Envista Holdings Corporation stock logo
NVST
Envista
12/16/2025Boost Price Target$21.91$22.00Neutral
AtriCure, Inc. stock logo
ATRC
AtriCure
12/16/2025Boost Price Target$41.45$48.00Overweight
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
11/7/2025Reiterated Rating$6.23$5.00Underweight
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
11/7/2025Lower Price Target$11.09$12.00Neutral
AtriCure, Inc. stock logo
ATRC
AtriCure
3/27/2025Lower Price Target$34.18$46.00Overweight
AtriCure, Inc. stock logo
ATRC
AtriCure
2/11/2025Boost Price Target$41.66$51.00Overweight